Use of Anti-platelet Agents after Traumatic Intracranial Hemorrhage

Anti-platelet therapies (APTs) are frequently utilized medications, and are commonly indicated in patients with traumatic intracranial hemorrhage (tICH). Although venous thromboembolism prophylaxis after tICH has been studied, no data exist to guide clinicians on when it is safe to initiate APTs [1]. Indications for APTs include ischemic stroke prevention after blunt cerebrovascular injury (BCVI), acute myocardial infarction treatment, and secondary prevention of heart attack and stroke [2–6].
Source: Clinical Neurology and Neurosurgery - Category: Neurosurgery Authors: Source Type: research